Possible structuro-functional association of pyracetam and vasopressin
TA Gudasheva, RU Ostrovskaya, FB Maksimova…
Index: Gudasheva, T. A.; Ostrovskaya, R. U.; Maksimova, F. B.; Trofimov, S. S.; Kosoi, M. Yu.; et al. Pharmaceutical Chemistry Journal, 1988 , vol. 22, # 3 p. 191 - 194 Khimiko-Farmatsevticheskii Zhurnal, 1988 , vol. 22, # 3 p. 271 - 275
Full Text: HTML
Citation Number: 1
Abstract
Recently considerable attention has been attracted by nootropic compounds, which specifically activate the higher integrative functions of the brain, affecting processes of learning and memory [2]. The main drug from this group of compounds is pyracetam (nootropyl, I). There are several~ Fpotheses on the mechanism of its action: i) it nonspeclfically accelerates neuronal metabolism on account of activation of the enzymes ...
Related Articles:
Designing nootropic dipeptides using an evolutionary-genetic approach
[Gudasheva, T. A.; Rozantsev, G. G.; Ostrovskaya, R. U.; Trofimov, S. S.; Voronina, T. A.; et al. Pharmaceutical Chemistry Journal, 1995 , vol. 29, # 1 p. 14 - 17 Khimiko-Farmatsevticheskii Zhurnal, 1995 , vol. 29, # 1 p. 15 - 18]
Designing nootropic dipeptides using an evolutionary-genetic approach
[Gudasheva; Trofimov; Morozova; Nikitin; Ostrovskaya; Voronina; Seredenin Pharmaceutical Chemistry Journal, 2006 , vol. 40, # 1 p. 18 - 22]